Piconol

Piconol

SCHEMBL7153449

OCc1ccccn1.[NaH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piconol SCHEMBL29266 0.97 — —
Piconol SCHEMBL29530498 0.97 — —
Piconol SCHEMBL11483938 0.95 — —
Piconol SCHEMBL2647157 0.95 — —
Piconol SCHEMBL10432457 0.95 HRH1 (0.52) —
Piconol SCHEMBL28642302 0.95 HRH1 (0.52) —
Piconol SCHEMBL31122945 0.95 — —
Piconol SCHEMBL15050907 0.95 — —
Piconol SCHEMBL3074525 0.95 — —
Piconol SCHEMBL19874569 0.95 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107805219-A It is a kind of that the method that Ibuprofen Piconol is reclaimed in waste material is produced from Ibuprofen Piconol 荆门医药工业技术研究院 2018-03-16 — — CN disclosed
US-6586441-B2 2-Amino-6-benzylsulfanyl-4-thiophen-2-yl-pyridine-3,5-dicarbo -nitrile as an examplary preferred compound; Alzheimer's and Parkinson's diseases; neuroprotectors; schizophrenia, analgesics; anxiolytic agents; respiratory disorders HOFFMAN-LA ROCHE INC. 2003-07-01 — — US disclosed
EP-1261327-A2 ADENOSINE RECEPTOR MODULATORS F.HOFFMANN-LA ROCHE AG (CH) 2002-12-04 — — EP disclosed
US-20010027196-A1 Adenosine receptor ligands and their use in the treatment of disease F. HOFFMANN-LA ROCHE AG (CH) 2001-10-04 — — US disclosed
WO-2001062233-A2 ADENOSINE RECEPTOR MODULATORS F. HOFFMANN LA ROCHE AG (CH) 2001-08-30 — — WO disclosed
Send feedback